<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Decker, Roy</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Invasive Mediastinal Staging is Not Necessary for Early-Stage NSCLC before SBRT</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">16-17</style></pages><abstract><style  face="normal" font="default" size="100%">Stereotactic body radiotherapy (SBRT) is a treatment option for patients with non-small cell lung cancer (NSCLC) who are not eligible for surgical intervention. The staging workup for patients with NSCLC receiving stereotactic SBRT requires an initial positron emission tomographic (PET) imaging. This article analyzes the use of invasive mediastinal staging methods compared to PET imaging alone in patients with NSCLC.</style></abstract><number><style face="normal" font="default" size="100%">31</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>